Related references
Note: Only part of the references are listed.Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus
Simon C. Warby et al.
HUMAN MOLECULAR GENETICS (2008)
N-terminal proteolysis of full-length mutant huntingtin in an inducible PC12 cell model of Huntington's disease
Tamara Ratovitski et al.
CELL CYCLE (2007)
The role of amyloid β peptide 42 in Alzheimer's disease
Mark A. Findeis
PHARMACOLOGY & THERAPEUTICS (2007)
Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models
Gabriele Schilling et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
Lysosomal proteases are involved in generation of N-terminal huntingtin fragments
YJ Kim et al.
NEUROBIOLOGY OF DISEASE (2006)
Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin
Y Tanaka et al.
NEUROBIOLOGY OF DISEASE (2006)
Determination of peptide substrate specificity for μ-calpain by a peptide library-based approach -: The importance of promed side interactions
D Cuerrier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts
A Sawa et al.
NEUROBIOLOGY OF DISEASE (2005)
Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions
EJ Slow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease
E Hermel et al.
CELL DEATH AND DIFFERENTIATION (2004)
Inhibition of calpain cleavage of huntingtin reduces toxicity - Accumulation of calpain/caspase fragments in the nucleus
J Gafni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity
H Zhou et al.
JOURNAL OF CELL BIOLOGY (2003)
Huntingtin is degraded to small fragments by calpain after ischemic injury
MH Kim et al.
EXPERIMENTAL NEUROLOGY (2003)
Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation
S Igarashi et al.
NEUROREPORT (2003)
Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein
HB Jiang et al.
HUMAN MOLECULAR GENETICS (2003)
Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons
D Goffredo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Polyglutamine repeat length-dependent proteolysis of huntingtin
B Sun et al.
NEUROBIOLOGY OF DISEASE (2002)
Proteases acting on mutant Huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions
A Lunkes et al.
MOLECULAR CELL (2002)
Lessons from animal models of Huntington's disease
DC Rubinsztein
TRENDS IN GENETICS (2002)
Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment
PJ Muchowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis
YJ Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Isolation of a 40-kDa Huntingtin-associated protein
MF Peters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
CL Wellington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
